Hepatitis C virus infection in thoracic organ transplant recipients can be associated with significant morbidity and mortality. Hepatitis C virus infection in 16% of our transplant recipients was found to progress without the development of hepatitis C virus antibodies. Twenty percent of heart transplant recipients rapidly developed a syndrome of severe cholestatic liver disease in the presence of hepatitis C virus infection. Transmission of HCV with the organ from anti-HCV positive donors was observed in 50% of the cases. In the present paper we report prevalence and outcome of HCV infection in a series of 517 thoracic organ transplant recipients.
|Journal||Giornale Italiano di Malattie Infettive|
|Issue number||SUPPL. 1|
|Publication status||Published - 1998|
ASJC Scopus subject areas
- Microbiology (medical)